|
Conflict of Interest
Citations 91-100 of 151 total displayed.
|
Past content
(since Apr 1998):
|
- Controversies
Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
- Joseph D. Piorkowski Jr
JAMA 2004; 292: 2655-2657.
[Extract]
[Full text]
[PDF]
- Controversies
Authors’ Reply to Bayer’s Response to "Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis"
- Bruce M. Psaty; Curt D. Furberg; Wayne A. Ray; Noel S. Weiss
JAMA 2004; 292: 2658-2659.
[Extract]
[Full text]
[PDF]
- Capitol Health Call
NIH Panel Examines Conflicts
- Brian Vastag
JAMA 2004; 291: 684.
[Extract]
[Full text]
[PDF]
- Letters
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
- Jonathan B. Rosefsky
JAMA 2003; 290: 3070-b-3071-b.
[Extract]
[Full text]
[PDF]
- Letters
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
- Robert H. Palmer
JAMA 2003; 290: 3070-a.
[Extract]
[Full text]
[PDF]
- Letters
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities—Reply
- Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise Lotte Kjaergard
JAMA 2003; 290: 3071-a-3072-a.
[Extract]
[Full text]
[PDF]
- Letters
Results of Clinical Trials Sponsored by For-Profit vs Nonprofit Entities
- Stig Waldorff
JAMA 2003; 290: 3071.
[Extract]
[Full text]
[PDF]
- Letters
Psychological Aspects of Gifts From Drug Companies
- Dana Katz; Peter Mansfield; Robert Goodman; Leonore Tiefer; Jon Merz
JAMA 2003; 290: 2404-b-2405-b.
[Extract]
[Full text]
[PDF]
- Letters
Psychological Aspects of Gifts From Drug Companies
- Michael Tansey
JAMA 2003; 290: 2405-b-2406-b.
[Extract]
[Full text]
[PDF]
- Letters
Psychological Aspects of Gifts From Drug Companies
- Gary A. Tarshis
JAMA 2003; 290: 2405-a.
[Extract]
[Full text]
[PDF]
|
|
